Ali Zekri

715 total citations
38 papers, 583 citations indexed

About

Ali Zekri is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Ali Zekri has authored 38 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Cell Biology and 13 papers in Oncology. Recurrent topics in Ali Zekri's work include Microtubule and mitosis dynamics (7 papers), Retinoids in leukemia and cellular processes (7 papers) and Cancer-related Molecular Pathways (6 papers). Ali Zekri is often cited by papers focused on Microtubule and mitosis dynamics (7 papers), Retinoids in leukemia and cellular processes (7 papers) and Cancer-related Molecular Pathways (6 papers). Ali Zekri collaborates with scholars based in Iran, United States and Australia. Ali Zekri's co-authors include Seyed H. Ghaffari, Ardeshir Ghavamzadeh, Kamran Alimoghaddam, Mohammad Hossein Modarressi, Meysam Yousefi, Majid Momeny, Mina Tabrizi, Shahin Ahmadian, Alireza Imani and Hassan Fazilaty and has published in prestigious journals such as Life Sciences, European Journal of Pharmacology and Journal of Cellular Physiology.

In The Last Decade

Ali Zekri

34 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Zekri Iran 17 353 138 119 114 55 38 583
Chang‐Hun Rhee South Korea 13 384 1.1× 107 0.8× 71 0.6× 114 1.0× 38 0.7× 17 601
Chenfei Huang China 14 391 1.1× 95 0.7× 231 1.9× 196 1.7× 42 0.8× 19 615
Courtney Schaal United States 9 500 1.4× 184 1.3× 119 1.0× 124 1.1× 39 0.7× 10 744
Karl Deacon United Kingdom 12 431 1.2× 127 0.9× 78 0.7× 115 1.0× 24 0.4× 13 668
Kyung Hee Koo South Korea 9 487 1.4× 194 1.4× 95 0.8× 245 2.1× 42 0.8× 11 760
Shu Zhuo China 15 326 0.9× 85 0.6× 199 1.7× 123 1.1× 64 1.2× 22 674
Tim Kute United States 9 326 0.9× 110 0.8× 111 0.9× 114 1.0× 31 0.6× 9 752
Giacomo Canesin United States 15 424 1.2× 151 1.1× 47 0.4× 107 0.9× 65 1.2× 21 700
Danni Sun China 13 347 1.0× 95 0.7× 75 0.6× 80 0.7× 36 0.7× 26 594

Countries citing papers authored by Ali Zekri

Since Specialization
Citations

This map shows the geographic impact of Ali Zekri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Zekri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Zekri more than expected).

Fields of papers citing papers by Ali Zekri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Zekri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Zekri. The network helps show where Ali Zekri may publish in the future.

Co-authorship network of co-authors of Ali Zekri

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Zekri. A scholar is included among the top collaborators of Ali Zekri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Zekri. Ali Zekri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Talebi, Saeed, et al.. (2024). Pseudodendritic keratitis in citrullinemia; a report of an unusual and novel ocular finding in this metabolic disorder. American Journal of Ophthalmology Case Reports. 34. 102044–102044.
2.
Taheri, Mohammad, et al.. (2021). Expression Analysis of Long Non-Coding RNAs Related With FOXM1, GATA3, FOXA1 and ESR1 in Breast Tissues. Frontiers in Oncology. 11. 671418–671418. 8 indexed citations
3.
Hussen, Bashdar Mahmud, et al.. (2021). Expression of T helper 1-associated lncRNAs in breast cancer. Experimental and Molecular Pathology. 119. 104619–104619. 5 indexed citations
4.
Ghafouri‐Fard, Soudeh, et al.. (2020). Expression analysis of vimentin and the related lncRNA network in breast cancer. Experimental and Molecular Pathology. 115. 104439–104439. 27 indexed citations
5.
6.
Zekri, Ali, et al.. (2017). Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform. European Journal of Pharmacology. 820. 274–285. 18 indexed citations
7.
Zekri, Ali, et al.. (2017). Reactive oxygen species generation and increase in mitochondrial copy number. Anti-Cancer Drugs. 28(8). 841–851. 16 indexed citations
8.
Zekri, Ali, et al.. (2016). Significance of AZD1152 as a potential treatment against Aurora B overexpression in acute promyelocytic leukemia. Annals of Hematology. 95(7). 1031–1042. 11 indexed citations
9.
Eyvani, Haniyeh, Ali Zekri, Majid Momeny, et al.. (2016). Arsenic trioxide induces cell cycle arrest and alters DNA methylation patterns of cell cycle regulatory genes in colorectal cancer cells. Life Sciences. 167. 67–77. 33 indexed citations
10.
Estiar, Mehrdad A., Rezvan Esmaeili, Ali Zare, et al.. (2016). High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer. Clinical and Experimental Medicine. 17(4). 547–553. 9 indexed citations
11.
Ghaffari, Seyed H., Meysam Yousefi, Majid Zaki‐Dizaji, et al.. (2016). Arsenic Trioxide Induces Apoptosis and Incapacitates Proliferation and Invasive Properties of U87MG Glioblastoma Cells through a Possible NF-κB-Mediated Mechanism. Asian Pacific Journal of Cancer Prevention. 17(3). 1553–1564. 19 indexed citations
12.
Azizi, Yaser, Mahdieh Faghihi, Alireza Imani, et al.. (2015). Post-infarct treatment with [Pyr1]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats. European Journal of Pharmacology. 761. 101–108. 48 indexed citations
13.
14.
Noori–Daloii, Mohammad Reza & Ali Zekri. (2014). Genetic instability and centrosome abnormality in cancer. Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch. 24(3). 125–135.
15.
Yousefi, Meysam, et al.. (2014). Silibinin induces apoptosis and inhibits proliferation of estrogen receptor (ER)-negative breast carcinoma cells through suppression of nuclear factor kappa B activation.. PubMed. 17(5). 366–71. 18 indexed citations
16.
Zekri, Ali, Seyed H. Ghaffari, Marjan Yaghmaie, et al.. (2014). AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy. Tumor Biology. 36(2). 623–632. 17 indexed citations
17.
Moslehi, Azam, Fatemeh Nabavizadeh, Gholamreza Hassanzadeh, et al.. (2014). Naltrexone attenuates endoplasmic reticulum stress induced hepatic injury in mice. Acta Physiologica Hungarica. 101(3). 341–352. 14 indexed citations
18.
Riazi, Gholam Hossein, Ebrahim Azizi, Saeid Amanpour, et al.. (2014). FGF10: Type III Epithelial Mesenchymal Transition and Invasion in Breast Cancer Cell Lines. Journal of Cancer. 5(7). 537–547. 33 indexed citations
19.
Ghaffari, Seyed H., Davood Bashash, Ali Zekri, et al.. (2013). Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest. Annals of Hematology. 92(9). 1207–1220. 23 indexed citations
20.
Yousefi, Meysam, Seyed H. Ghaffari, Bahram M. Soltani, et al.. (2012). Therapeutic Efficacy of Silibinin on Human Neuroblastoma Cells: Akt and NF-κB Expressions May Play an Important Role in Silibinin-Induced Response. Neurochemical Research. 37(9). 2053–2063. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chang‐Hun Rhee Breakdown of academic impact, for papers by Chenfei Huang Breakdown of academic impact, for papers by Courtney Schaal Breakdown of academic impact, for papers by Karl Deacon Breakdown of academic impact, for papers by Kyung Hee Koo Breakdown of academic impact, for papers by Shu Zhuo Breakdown of academic impact, for papers by Tim Kute Breakdown of academic impact, for papers by Giacomo Canesin Breakdown of academic impact, for papers by Danni Sun
Rankless by CCL
2026